David Riches
Concepts (395)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Idiopathic Pulmonary Fibrosis | 10 | 2023 | 510 | 2.700 |
Why?
| Lung | 23 | 2022 | 3595 | 2.050 |
Why?
| Pulmonary Fibrosis | 12 | 2019 | 323 | 1.990 |
Why?
| Bleomycin | 13 | 2021 | 228 | 1.680 |
Why?
| Apoptosis | 16 | 2023 | 2368 | 1.490 |
Why?
| fas Receptor | 6 | 2020 | 92 | 1.450 |
Why?
| Arthritis, Experimental | 3 | 2018 | 132 | 1.270 |
Why?
| Fibroblasts | 12 | 2023 | 839 | 1.200 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 7 | 2010 | 72 | 1.140 |
Why?
| Macrophages | 15 | 2018 | 1267 | 1.030 |
Why?
| Signal Transduction | 17 | 2020 | 4527 | 0.990 |
Why?
| Receptors, Tumor Necrosis Factor | 5 | 2005 | 139 | 0.930 |
Why?
| Tumor Necrosis Factor-alpha | 10 | 2014 | 1138 | 0.910 |
Why?
| Insulin-Like Growth Factor I | 5 | 2009 | 286 | 0.880 |
Why?
| Lung Injury | 3 | 2019 | 198 | 0.870 |
Why?
| Trans-Activators | 4 | 2015 | 368 | 0.870 |
Why?
| Mice | 43 | 2023 | 14934 | 0.800 |
Why?
| Collagen | 5 | 2018 | 416 | 0.770 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2018 | 7 | 0.750 |
Why?
| Epithelial Cells | 8 | 2023 | 956 | 0.750 |
Why?
| Immunity, Innate | 4 | 2018 | 723 | 0.740 |
Why?
| Macrophages, Alveolar | 3 | 2014 | 351 | 0.740 |
Why?
| TRPC Cation Channels | 2 | 2010 | 11 | 0.730 |
Why?
| Alveolar Epithelial Cells | 5 | 2023 | 96 | 0.680 |
Why?
| Animals | 49 | 2023 | 31884 | 0.670 |
Why?
| Indoles | 2 | 2019 | 306 | 0.660 |
Why?
| Antigens, CD | 4 | 2004 | 441 | 0.600 |
Why?
| Lung Diseases, Interstitial | 4 | 2023 | 515 | 0.580 |
Why?
| Myofibroblasts | 1 | 2018 | 116 | 0.570 |
Why?
| Mice, Inbred C57BL | 18 | 2021 | 4718 | 0.530 |
Why?
| Mice, Knockout | 13 | 2020 | 2586 | 0.520 |
Why?
| Interleukin-4 | 3 | 2008 | 209 | 0.510 |
Why?
| Serum Response Factor | 1 | 2015 | 28 | 0.490 |
Why?
| Cells, Cultured | 15 | 2020 | 3897 | 0.480 |
Why?
| Pneumonia | 3 | 2018 | 569 | 0.470 |
Why?
| Arthritis, Rheumatoid | 2 | 2013 | 1002 | 0.460 |
Why?
| Mesoderm | 1 | 2015 | 138 | 0.460 |
Why?
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 164 | 0.460 |
Why?
| TNF Receptor-Associated Factor 2 | 3 | 2010 | 8 | 0.440 |
Why?
| NF-kappa B | 5 | 2009 | 637 | 0.440 |
Why?
| Acute Lung Injury | 2 | 2017 | 300 | 0.420 |
Why?
| Disease Models, Animal | 6 | 2020 | 3547 | 0.410 |
Why?
| Dendritic Cells | 2 | 2013 | 436 | 0.390 |
Why?
| Monocytes | 5 | 2018 | 503 | 0.390 |
Why?
| Cell Line | 10 | 2019 | 2645 | 0.380 |
Why?
| Receptor, Muscarinic M1 | 1 | 2010 | 2 | 0.370 |
Why?
| Transforming Growth Factor beta | 5 | 2020 | 448 | 0.360 |
Why?
| Up-Regulation | 4 | 2012 | 812 | 0.360 |
Why?
| Adaptive Immunity | 1 | 2011 | 156 | 0.350 |
Why?
| Testosterone | 1 | 2013 | 343 | 0.340 |
Why?
| X-Ray Microtomography | 2 | 2021 | 74 | 0.340 |
Why?
| Silicosis | 2 | 2023 | 21 | 0.340 |
Why?
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 20 | 0.330 |
Why?
| Lung Compliance | 3 | 2014 | 49 | 0.310 |
Why?
| JNK Mitogen-Activated Protein Kinases | 3 | 2011 | 144 | 0.310 |
Why?
| Interleukin-13 | 2 | 2010 | 123 | 0.300 |
Why?
| Phagocytosis | 5 | 2012 | 352 | 0.290 |
Why?
| Autoimmunity | 1 | 2013 | 818 | 0.290 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 2 | 2020 | 23 | 0.290 |
Why?
| Transcription Factor AP-1 | 2 | 2006 | 80 | 0.280 |
Why?
| Lung Diseases | 1 | 2013 | 703 | 0.280 |
Why?
| Inflammation Mediators | 3 | 2018 | 476 | 0.270 |
Why?
| Th2 Cells | 2 | 2004 | 155 | 0.260 |
Why?
| Membrane Microdomains | 2 | 2004 | 32 | 0.260 |
Why?
| Sodium Chloride | 1 | 2006 | 136 | 0.250 |
Why?
| Granulomatous Disease, Chronic | 3 | 2010 | 60 | 0.250 |
Why?
| Chemokines | 1 | 2006 | 213 | 0.250 |
Why?
| Humans | 37 | 2023 | 115219 | 0.240 |
Why?
| Respiratory Mucosa | 4 | 2019 | 251 | 0.240 |
Why?
| Proline | 1 | 2005 | 72 | 0.240 |
Why?
| 5' Untranslated Regions | 1 | 2005 | 51 | 0.240 |
Why?
| Calcium | 1 | 2010 | 1104 | 0.240 |
Why?
| Flow Cytometry | 3 | 2020 | 1084 | 0.240 |
Why?
| Interferon-gamma | 4 | 2010 | 724 | 0.230 |
Why?
| Dual Specificity Phosphatase 1 | 3 | 2012 | 28 | 0.230 |
Why?
| Keratin-8 | 1 | 2023 | 3 | 0.230 |
Why?
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2003 | 4 | 0.230 |
Why?
| Transcription, Genetic | 4 | 2014 | 1317 | 0.230 |
Why?
| Cytokines | 5 | 2018 | 1843 | 0.220 |
Why?
| Gene Expression Regulation | 4 | 2010 | 2330 | 0.220 |
Why?
| Precancerous Conditions | 1 | 2004 | 156 | 0.220 |
Why?
| Adenoma | 1 | 2004 | 187 | 0.210 |
Why?
| Stem Cells | 2 | 2019 | 547 | 0.210 |
Why?
| Neutrophils | 4 | 2018 | 1163 | 0.210 |
Why?
| Gene Expression Profiling | 4 | 2020 | 1524 | 0.200 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 193 | 0.200 |
Why?
| Promoter Regions, Genetic | 2 | 2008 | 1133 | 0.190 |
Why?
| Proteins | 4 | 2004 | 915 | 0.190 |
Why?
| Pulmonary Alveoli | 2 | 2017 | 374 | 0.190 |
Why?
| Cell Communication | 2 | 2018 | 280 | 0.190 |
Why?
| Male | 16 | 2021 | 55811 | 0.180 |
Why?
| Mice, Mutant Strains | 3 | 2011 | 272 | 0.180 |
Why?
| Transcription Factors | 3 | 2011 | 1531 | 0.180 |
Why?
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 590 | 0.180 |
Why?
| Endoplasmic Reticulum | 3 | 2011 | 234 | 0.170 |
Why?
| Smoke | 2 | 2011 | 127 | 0.170 |
Why?
| Mice, Inbred C3H | 3 | 2005 | 242 | 0.170 |
Why?
| Lymph Nodes | 2 | 2013 | 422 | 0.170 |
Why?
| Mice, Transgenic | 4 | 2019 | 1956 | 0.170 |
Why?
| Fibroblast Growth Factor 10 | 1 | 2019 | 24 | 0.170 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 21 | 0.170 |
Why?
| Enzyme Activation | 5 | 2011 | 791 | 0.170 |
Why?
| Single-Cell Analysis | 1 | 2020 | 186 | 0.160 |
Why?
| Molecular Sequence Data | 4 | 2010 | 2797 | 0.160 |
Why?
| Transfection | 3 | 2009 | 872 | 0.160 |
Why?
| Case-Control Studies | 3 | 2018 | 3023 | 0.160 |
Why?
| Tissue Culture Techniques | 1 | 2018 | 66 | 0.160 |
Why?
| Drug Resistance, Microbial | 1 | 2018 | 67 | 0.160 |
Why?
| Down-Regulation | 2 | 2018 | 598 | 0.150 |
Why?
| Biopsy, Needle | 1 | 2018 | 183 | 0.150 |
Why?
| Cell Differentiation | 3 | 2023 | 1700 | 0.150 |
Why?
| Lipopolysaccharides | 4 | 2012 | 818 | 0.150 |
Why?
| Sex Characteristics | 2 | 2013 | 639 | 0.150 |
Why?
| COS Cells | 4 | 2005 | 175 | 0.150 |
Why?
| Imaging, Three-Dimensional | 1 | 2021 | 538 | 0.150 |
Why?
| Mice, Inbred BALB C | 3 | 2011 | 1155 | 0.140 |
Why?
| Female | 12 | 2019 | 59717 | 0.140 |
Why?
| Disease Progression | 2 | 2021 | 2390 | 0.140 |
Why?
| Mutagenesis, Site-Directed | 2 | 2010 | 345 | 0.140 |
Why?
| Homeostasis | 1 | 2020 | 578 | 0.140 |
Why?
| Reference Values | 1 | 2018 | 748 | 0.140 |
Why?
| Fibrosis | 2 | 2019 | 455 | 0.140 |
Why?
| Lung Neoplasms | 2 | 2009 | 2200 | 0.140 |
Why?
| Phosphorylation | 6 | 2020 | 1574 | 0.140 |
Why?
| RNA, Small Interfering | 1 | 2018 | 541 | 0.130 |
Why?
| Hydrogels | 1 | 2022 | 575 | 0.130 |
Why?
| NADPH Oxidases | 3 | 2010 | 120 | 0.130 |
Why?
| Extracellular Matrix | 2 | 2019 | 436 | 0.130 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 249 | 0.130 |
Why?
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 74 | 0.130 |
Why?
| Permeability | 2 | 2017 | 148 | 0.120 |
Why?
| Fas Ligand Protein | 2 | 2013 | 58 | 0.120 |
Why?
| TNF Receptor-Associated Factor 1 | 3 | 2003 | 7 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 796 | 0.120 |
Why?
| Blotting, Western | 6 | 2015 | 1150 | 0.120 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 287 | 0.120 |
Why?
| Cell Membrane | 2 | 2010 | 681 | 0.120 |
Why?
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 7 | 0.120 |
Why?
| Extracellular Vesicles | 1 | 2015 | 83 | 0.120 |
Why?
| Gene Expression | 3 | 2012 | 1424 | 0.120 |
Why?
| Tacrolimus Binding Proteins | 1 | 2014 | 16 | 0.120 |
Why?
| Hydroxyproline | 1 | 2014 | 22 | 0.120 |
Why?
| Binding Sites | 2 | 2010 | 1173 | 0.120 |
Why?
| Immunohistochemistry | 1 | 2018 | 1635 | 0.120 |
Why?
| Recombinant Proteins | 2 | 2010 | 1237 | 0.120 |
Why?
| Sequence Deletion | 2 | 2005 | 168 | 0.110 |
Why?
| Remission Induction | 1 | 2014 | 237 | 0.110 |
Why?
| Amino Acid Sequence | 2 | 2010 | 1990 | 0.110 |
Why?
| Proteolysis | 1 | 2013 | 144 | 0.110 |
Why?
| Transcriptional Activation | 2 | 2005 | 337 | 0.100 |
Why?
| Delayed-Action Preparations | 1 | 2012 | 159 | 0.100 |
Why?
| Cell Lineage | 1 | 2013 | 310 | 0.100 |
Why?
| GTPase-Activating Proteins | 1 | 2012 | 71 | 0.100 |
Why?
| Pyridones | 1 | 2012 | 125 | 0.100 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2011 | 23 | 0.100 |
Why?
| Ventilator-Induced Lung Injury | 1 | 2012 | 49 | 0.100 |
Why?
| Oxidative Stress | 3 | 2015 | 1086 | 0.100 |
Why?
| Autophagy | 1 | 2013 | 234 | 0.100 |
Why?
| Chemokine CXCL1 | 1 | 2011 | 66 | 0.100 |
Why?
| Wound Healing | 2 | 2017 | 259 | 0.100 |
Why?
| Interleukin-8 | 2 | 2009 | 238 | 0.090 |
Why?
| Protein Structure, Tertiary | 2 | 2005 | 798 | 0.090 |
Why?
| Cell Line, Transformed | 1 | 2011 | 133 | 0.090 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 54 | 0.090 |
Why?
| Trauma Severity Indices | 1 | 2011 | 111 | 0.090 |
Why?
| Macrophage Activation | 2 | 2009 | 164 | 0.090 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2011 | 91 | 0.090 |
Why?
| Chemokine CXCL2 | 2 | 2010 | 37 | 0.090 |
Why?
| Endocytosis | 1 | 2011 | 151 | 0.090 |
Why?
| Schistosoma mansoni | 1 | 2010 | 33 | 0.090 |
Why?
| Antigen Presentation | 1 | 2011 | 189 | 0.090 |
Why?
| Cell Proliferation | 3 | 2017 | 2192 | 0.090 |
Why?
| Recovery of Function | 1 | 2014 | 577 | 0.090 |
Why?
| RNA, Messenger | 3 | 2011 | 2563 | 0.090 |
Why?
| Protein Transport | 3 | 2011 | 398 | 0.090 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 276 | 0.090 |
Why?
| Mitochondria | 1 | 2015 | 750 | 0.090 |
Why?
| Schistosomiasis | 1 | 2010 | 37 | 0.090 |
Why?
| Granuloma | 1 | 2010 | 85 | 0.090 |
Why?
| Peritonitis | 1 | 2010 | 76 | 0.090 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 299 | 0.090 |
Why?
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 139 | 0.090 |
Why?
| HeLa Cells | 3 | 2013 | 562 | 0.080 |
Why?
| Antigens | 1 | 2011 | 318 | 0.080 |
Why?
| NIH 3T3 Cells | 2 | 2014 | 137 | 0.080 |
Why?
| Thiazolidinediones | 1 | 2010 | 143 | 0.080 |
Why?
| MicroRNAs | 1 | 2015 | 604 | 0.080 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2009 | 103 | 0.080 |
Why?
| PPAR gamma | 1 | 2010 | 184 | 0.080 |
Why?
| Drug Delivery Systems | 1 | 2012 | 296 | 0.080 |
Why?
| Intubation, Intratracheal | 1 | 2011 | 215 | 0.080 |
Why?
| Elastin | 1 | 2009 | 78 | 0.080 |
Why?
| Nanoparticles | 1 | 2012 | 313 | 0.080 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 157 | 0.080 |
Why?
| Superoxide Dismutase | 1 | 2010 | 305 | 0.080 |
Why?
| Vitamin D | 1 | 2012 | 340 | 0.080 |
Why?
| DEAD-box RNA Helicases | 1 | 2009 | 56 | 0.080 |
Why?
| Myoblasts | 1 | 2009 | 77 | 0.080 |
Why?
| Phosphatidylserines | 1 | 2008 | 87 | 0.080 |
Why?
| Respiration, Artificial | 1 | 2012 | 527 | 0.080 |
Why?
| Glucocorticoids | 2 | 2012 | 539 | 0.080 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 371 | 0.080 |
Why?
| Hypersensitivity | 1 | 2011 | 256 | 0.070 |
Why?
| Asthma | 2 | 2012 | 2051 | 0.070 |
Why?
| Receptors, Cell Surface | 1 | 2009 | 356 | 0.070 |
Why?
| Prednisone | 1 | 2008 | 233 | 0.070 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 61 | 0.070 |
Why?
| DNA-Binding Proteins | 2 | 2005 | 1318 | 0.070 |
Why?
| Interleukin-1beta | 1 | 2009 | 370 | 0.070 |
Why?
| Models, Biological | 2 | 2013 | 1638 | 0.070 |
Why?
| Survival Rate | 1 | 2011 | 1650 | 0.070 |
Why?
| Cell Survival | 2 | 2013 | 1022 | 0.070 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2009 | 401 | 0.070 |
Why?
| Genetic Vectors | 2 | 2011 | 291 | 0.070 |
Why?
| Vaccines | 1 | 2011 | 376 | 0.070 |
Why?
| Fas-Associated Death Domain Protein | 1 | 2005 | 8 | 0.070 |
Why?
| Sex Factors | 1 | 2011 | 1722 | 0.070 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2004 | 278 | 0.060 |
Why?
| Metalloendopeptidases | 1 | 2005 | 55 | 0.060 |
Why?
| Consensus Sequence | 1 | 2005 | 70 | 0.060 |
Why?
| Nitric Oxide | 1 | 2010 | 827 | 0.060 |
Why?
| Inflammation | 4 | 2012 | 2485 | 0.060 |
Why?
| Colorado | 1 | 2015 | 4099 | 0.060 |
Why?
| Asparagine | 1 | 2005 | 29 | 0.060 |
Why?
| Sp3 Transcription Factor | 1 | 2005 | 6 | 0.060 |
Why?
| Base Sequence | 2 | 2009 | 2120 | 0.060 |
Why?
| Luciferases | 1 | 2005 | 142 | 0.060 |
Why?
| Longitudinal Studies | 1 | 2011 | 2388 | 0.060 |
Why?
| Serine | 1 | 2005 | 126 | 0.060 |
Why?
| Cytoplasm | 1 | 2005 | 256 | 0.060 |
Why?
| Point Mutation | 1 | 2005 | 217 | 0.060 |
Why?
| Amino Acid Substitution | 1 | 2005 | 262 | 0.060 |
Why?
| Growth Substances | 1 | 2004 | 137 | 0.060 |
Why?
| Hyperplasia | 1 | 2004 | 165 | 0.060 |
Why?
| Culture Media, Conditioned | 1 | 2004 | 105 | 0.060 |
Why?
| Antibiotics, Antineoplastic | 1 | 2004 | 109 | 0.060 |
Why?
| Age Factors | 1 | 2011 | 2900 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 928 | 0.060 |
Why?
| rac GTP-Binding Proteins | 1 | 2004 | 34 | 0.060 |
Why?
| Exons | 1 | 2005 | 301 | 0.060 |
Why?
| TNF Receptor-Associated Death Domain Protein | 1 | 2003 | 2 | 0.060 |
Why?
| CD36 Antigens | 1 | 2004 | 37 | 0.060 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 13 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 146 | 0.060 |
Why?
| STAT6 Transcription Factor | 1 | 2003 | 22 | 0.060 |
Why?
| Time Factors | 1 | 2014 | 6157 | 0.060 |
Why?
| STAT1 Transcription Factor | 1 | 2003 | 64 | 0.050 |
Why?
| Drug Synergism | 1 | 2003 | 317 | 0.050 |
Why?
| Silicon Dioxide | 1 | 2003 | 89 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2005 | 399 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2003 | 524 | 0.050 |
Why?
| Thorax | 1 | 2022 | 41 | 0.050 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 172 | 0.050 |
Why?
| Adenoviridae | 2 | 2014 | 184 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 213 | 0.050 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 1902 | 0.050 |
Why?
| Rats | 3 | 2017 | 4980 | 0.050 |
Why?
| Jurkat Cells | 2 | 2013 | 127 | 0.050 |
Why?
| Proto-Oncogene Proteins | 1 | 2004 | 609 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 1558 | 0.050 |
Why?
| Gene Deletion | 2 | 2014 | 356 | 0.050 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2109 | 0.050 |
Why?
| Obesity | 1 | 2012 | 2525 | 0.040 |
Why?
| Prospective Studies | 1 | 2011 | 6245 | 0.040 |
Why?
| Middle Aged | 3 | 2012 | 26872 | 0.040 |
Why?
| NADPH Oxidase 2 | 2 | 2010 | 42 | 0.040 |
Why?
| Aged | 2 | 2009 | 19135 | 0.040 |
Why?
| Hypertension, Pulmonary | 1 | 2010 | 1744 | 0.040 |
Why?
| Scleroderma, Systemic | 1 | 2019 | 96 | 0.040 |
Why?
| Dexamethasone | 2 | 2012 | 317 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 746 | 0.040 |
Why?
| Regeneration | 1 | 2019 | 161 | 0.040 |
Why?
| Reactive Oxygen Species | 2 | 2010 | 536 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 262 | 0.040 |
Why?
| Membrane Glycoproteins | 2 | 2010 | 429 | 0.040 |
Why?
| Chemokine CXCL12 | 1 | 2017 | 74 | 0.040 |
Why?
| Receptors, CXCR4 | 1 | 2017 | 78 | 0.040 |
Why?
| Rats, Sprague-Dawley | 2 | 2012 | 2216 | 0.030 |
Why?
| Enzyme Induction | 2 | 2008 | 84 | 0.030 |
Why?
| Anti-Inflammatory Agents | 1 | 2019 | 451 | 0.030 |
Why?
| Arrestins | 1 | 2015 | 14 | 0.030 |
Why?
| Toll-Like Receptor 9 | 1 | 2015 | 30 | 0.030 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2015 | 90 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2015 | 410 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2022 | 2552 | 0.030 |
Why?
| Cell-Derived Microparticles | 1 | 2015 | 58 | 0.030 |
Why?
| Toll-Like Receptors | 1 | 2015 | 166 | 0.030 |
Why?
| Actins | 2 | 2009 | 383 | 0.030 |
Why?
| Exosomes | 1 | 2015 | 91 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2017 | 499 | 0.030 |
Why?
| Receptors, Immunologic | 1 | 2015 | 201 | 0.030 |
Why?
| Protein Binding | 2 | 2013 | 1898 | 0.030 |
Why?
| Smad Proteins | 1 | 2014 | 39 | 0.030 |
Why?
| Sequestosome-1 Protein | 1 | 2013 | 13 | 0.030 |
Why?
| Risk Factors | 2 | 2022 | 8658 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 52 | 0.030 |
Why?
| Young Adult | 1 | 2009 | 10519 | 0.030 |
Why?
| Protein Kinase Inhibitors | 1 | 2019 | 787 | 0.030 |
Why?
| Chloroquine | 1 | 2013 | 52 | 0.030 |
Why?
| Antigens, Ly | 1 | 2013 | 45 | 0.030 |
Why?
| Culture Media | 1 | 2013 | 155 | 0.030 |
Why?
| Genes, Reporter | 1 | 2014 | 257 | 0.030 |
Why?
| Polyglactin 910 | 1 | 2012 | 10 | 0.030 |
Why?
| PPAR delta | 1 | 2012 | 6 | 0.030 |
Why?
| Toll-Like Receptor 4 | 1 | 2015 | 286 | 0.030 |
Why?
| Endothelium | 1 | 2013 | 112 | 0.030 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3250 | 0.030 |
Why?
| Receptors, Chemokine | 1 | 2012 | 43 | 0.030 |
Why?
| Cyclooxygenase 2 | 1 | 2013 | 164 | 0.030 |
Why?
| Bronchoalveolar Lavage | 1 | 2012 | 84 | 0.030 |
Why?
| Diterpenes | 1 | 2012 | 31 | 0.030 |
Why?
| Prone Position | 1 | 2012 | 27 | 0.030 |
Why?
| Supine Position | 1 | 2012 | 34 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2013 | 373 | 0.030 |
Why?
| I-kappa B Proteins | 1 | 2012 | 78 | 0.020 |
Why?
| Mice, 129 Strain | 1 | 2012 | 76 | 0.020 |
Why?
| Histocompatibility Antigens Class II | 1 | 2013 | 353 | 0.020 |
Why?
| Caspase 12 | 1 | 2011 | 1 | 0.020 |
Why?
| Aldehydes | 1 | 2012 | 142 | 0.020 |
Why?
| Phenotype | 1 | 2019 | 2814 | 0.020 |
Why?
| Thapsigargin | 1 | 2011 | 18 | 0.020 |
Why?
| Staurosporine | 1 | 2011 | 21 | 0.020 |
Why?
| Instillation, Drug | 1 | 2011 | 9 | 0.020 |
Why?
| Cyclin D1 | 1 | 2011 | 61 | 0.020 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2011 | 57 | 0.020 |
Why?
| Receptors, Glucocorticoid | 1 | 2012 | 131 | 0.020 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2011 | 119 | 0.020 |
Why?
| Adolescent | 1 | 2009 | 17887 | 0.020 |
Why?
| Recombinant Fusion Proteins | 1 | 2013 | 616 | 0.020 |
Why?
| Onium Compounds | 1 | 2010 | 10 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2012 | 267 | 0.020 |
Why?
| Sputum | 1 | 2012 | 285 | 0.020 |
Why?
| Zymosan | 1 | 2010 | 63 | 0.020 |
Why?
| Smad3 Protein | 1 | 2010 | 41 | 0.020 |
Why?
| Smad2 Protein | 1 | 2010 | 33 | 0.020 |
Why?
| Cadherins | 1 | 2011 | 175 | 0.020 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 271 | 0.020 |
Why?
| Endomyocardial Fibrosis | 1 | 2009 | 3 | 0.020 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2011 | 167 | 0.020 |
Why?
| Survivors | 1 | 2013 | 409 | 0.020 |
Why?
| Ventricular Pressure | 1 | 2009 | 37 | 0.020 |
Why?
| Janus Kinase 2 | 1 | 2009 | 31 | 0.020 |
Why?
| Stress Fibers | 1 | 2009 | 16 | 0.020 |
Why?
| beta Catenin | 1 | 2011 | 220 | 0.020 |
Why?
| Amiloride | 1 | 2009 | 23 | 0.020 |
Why?
| Viral Load | 1 | 2011 | 405 | 0.020 |
Why?
| STAT5 Transcription Factor | 1 | 2009 | 44 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 2009 | 192 | 0.020 |
Why?
| Receptors, IgG | 1 | 2009 | 67 | 0.020 |
Why?
| rhoA GTP-Binding Protein | 1 | 2009 | 73 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2012 | 1000 | 0.020 |
Why?
| Cell Movement | 1 | 2013 | 866 | 0.020 |
Why?
| RNA Splice Sites | 1 | 2009 | 34 | 0.020 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2009 | 14 | 0.020 |
Why?
| Skin | 1 | 2013 | 659 | 0.020 |
Why?
| Codon, Nonsense | 1 | 2009 | 37 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2009 | 396 | 0.020 |
Why?
| Receptors, Interleukin-1 | 1 | 2009 | 227 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2009 | 245 | 0.020 |
Why?
| Drug Resistance | 1 | 2008 | 159 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2009 | 449 | 0.020 |
Why?
| Gene Frequency | 1 | 2009 | 483 | 0.020 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2008 | 157 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 1231 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 753 | 0.020 |
Why?
| Risk | 1 | 2009 | 816 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2009 | 728 | 0.020 |
Why?
| COP-Coated Vesicles | 1 | 2005 | 2 | 0.020 |
Why?
| Myocytes, Cardiac | 1 | 2009 | 451 | 0.020 |
Why?
| Adult | 3 | 2012 | 30708 | 0.020 |
Why?
| ADAM17 Protein | 1 | 2005 | 31 | 0.020 |
Why?
| Threonine | 1 | 2005 | 40 | 0.020 |
Why?
| ADAM Proteins | 1 | 2005 | 58 | 0.020 |
Why?
| Golgi Apparatus | 1 | 2005 | 89 | 0.020 |
Why?
| Interleukin-6 | 1 | 2008 | 676 | 0.010 |
Why?
| Erythrocytes | 1 | 2009 | 592 | 0.010 |
Why?
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2004 | 3 | 0.010 |
Why?
| Guanine Nucleotides | 1 | 2004 | 15 | 0.010 |
Why?
| Cell Surface Extensions | 1 | 2004 | 11 | 0.010 |
Why?
| Genetic Variation | 1 | 2009 | 876 | 0.010 |
Why?
| Cell Size | 1 | 2004 | 81 | 0.010 |
Why?
| rac1 GTP-Binding Protein | 1 | 2004 | 56 | 0.010 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 55 | 0.010 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 929 | 0.010 |
Why?
| Cohort Studies | 1 | 2012 | 4917 | 0.010 |
Why?
| Cytoskeleton | 1 | 2004 | 177 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1203 | 0.010 |
Why?
| Biomarkers | 1 | 2012 | 3421 | 0.010 |
Why?
| Bone Marrow | 1 | 2004 | 248 | 0.010 |
Why?
| Quality of Life | 1 | 2013 | 2364 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2004 | 398 | 0.010 |
Why?
| Microtubules | 1 | 2004 | 237 | 0.010 |
Why?
| Cystic Fibrosis | 1 | 2008 | 957 | 0.010 |
Why?
| Mutation | 1 | 2004 | 3350 | 0.010 |
Why?
| Child | 1 | 2008 | 18466 | 0.010 |
Why?
|
|
Riches's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|